By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > What Every Healthcare Leader Should Know About Long COVID’s $8 Billion Price

What Every Healthcare Leader Should Know About Long COVID’s $8 Billion Price

GMJ
Last updated: 27/06/2026 01:19
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Healthcare cost analysis showing long COVID economic impact on US system
New analysis reveals long COVID could burden the US healthcare system with $8 billion in costs over three years. Treatment capacity shortages and workforce losses compound the financial impact. — Photo: www.kaboompics.com / Pexels
SHARE
1 min read|130 words

As long COVID cases mount, three critical realities demand immediate attention from healthcare administrators and policymakers. First, direct healthcare services account for $3.6 billion of the projected $8 billion burden, reflecting the substantial per-patient costs required for managing complex, multisystem symptoms. Second, workforce productivity losses represent the largest economic component, meaning long COVID’s impact extends far beyond clinical settings into employment, disability claims, and economic participation. Third, federal defunding of specialized research and treatment programs comes at precisely the wrong moment, reducing capacity when demand peaks. These findings highlight a critical gap: patients need specialized, coordinated care approaches, yet the healthcare system lacks adequate infrastructure and resources. Healthcare leaders must advocate for increased funding, workforce training in long COVID management, and integrated care models that address both clinical recovery and workforce reintegration.

Was this article helpful?

GMJ Brief · Takeaway

📰 Read the full article: Long COVID Could Cost US Healthcare System $8 Billion Over Three Years →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
California Hospital Groups Launch Competing Ballot Initiatives on Healthcare Worker Wages

California's healthcare sector faces competing ballot initiatives from worker unions and hospital…

UK Health Security Agency Publishes New Hantavirus Transmission Parameters for Public Health Response

UK Health Security Agency releases comprehensive guidance on hantavirus human-to-human transmission parameters.…

FDA Approves Sanofi’s Teplizumab for Children with Stage 3 Type 1 Diabetes

FDA approves Sanofi's teplizumab for children with stage 3 type 1 diabetes,…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

PHEIC Declaration: Ebola Cross-Border Transmission DRC-Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Microscopic image of chikungunya virus particles and infected joint tissue

40% of Chikungunya Patients Face Chronic Joint Complications

By
Prof. Giorgi Pkhakadze
14/06/2026

PHEIC Declaration: Ebola Cross-Border Transmission DRC-Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Brain scan images showing cognitive changes during perimenopause transition

Clinical Studies Confirm Perimenopause Brain Fog Is Real Biology, Not Psychology

By
Prof. Giorgi Pkhakadze
26/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up